TamCarg Profile Banner
Tamsin Cargill Profile
Tamsin Cargill

@TamCarg

Followers
362
Following
1K
Media
44
Statuses
1K

@NIHRresearch Gastro-Hepatology ACL @TGU_Oxford working with the @DeLIVER_HCC team, Hepatology at home #POCUS

Oxford
Joined July 2010
Don't wanna be here? Send us removal request.
@DrFalkUK
DR FALK
6 hours
Congratulations Dr Tamsin Cargill Winner of 2025 Falk Foundation/@Basledu/@LiverTrust Qual & Service Improvement Award. View project 'Hepatology at home: novel pathway for the integrated management of patients with LD in the home: https://t.co/WIxVFKEI7Q @TamCarg @OUH_Liverunit
1
3
4
@bmj_latest
The BMJ
4 days
“You can make a diagnosis, explain it to the patient and their family, and start treatment—all without moving them. It’s effective and personal.” @DanLasserson explains why ambulatory care is so rewarding https://t.co/Lv1Swp7S93
Tweet card summary image
bmj.com
Helen Jones speaks to Dan Lasserson about switching from philosophy to medicine, and why ambulatory care is so rewarding “I tried not to be a doctor,” says Dan Lasserson, professor of acute ambulat...
0
3
14
@TamCarg
Tamsin Cargill
4 days
Brilliant EASL Studio debating the place of ACLF in clinical practise, prognostication and defining new treatment paradigms. Expertly facilitated by @tom_marjot in discussion with @ProfPaoloAngeli and Julia Wendon @EASLedu
@EASLnews
EASLnews
7 days
Catch up on this week's EASL Studio thought-provoking episode! Experts debate the real-world utility of prognostic scores, the clarity (or confusion) created by multiple definitions, and whether the ACLF concept drives urgency, facilitates transplant access, or improves outcomes.
0
2
13
@BryonyRChapman
Bryony Chapman
7 days
Delighted that our team has won the Dr Falk/BASL/BLT Service Improvement Award for our Hepatology@Home service, an extension of our Hepatology Ambulatory Unit. A huge thank you to @TamCarg for your ongoing support and commitment to this service! @OUH_Liverunit @OUHospitals
@TamCarg
Tamsin Cargill
7 days
Really honoured to be part of the brilliant Hepatology at home team @BryonyRChapman @DanLasserson @SophieMcGlen @Dr_Sam_Mill @esaunsbury winners of Falk/BASL/BLT service improvement award @BASLedu read our @FrontGastro_BMJ paper here
1
4
10
@TamCarg
Tamsin Cargill
7 days
Really honoured to be part of the brilliant Hepatology at home team @BryonyRChapman @DanLasserson @SophieMcGlen @Dr_Sam_Mill @esaunsbury winners of Falk/BASL/BLT service improvement award @BASLedu read our @FrontGastro_BMJ paper here
Tweet card summary image
fg.bmj.com
Objective Hospital admissions and deaths due to liver disease are increasing worldwide, representing a significant burden on acute services. We describe the first 12 months of Hepatology at home , a...
@DrFalkUK
DR FALK
7 days
Huge congratulations to the worthy winners of the 2026 Falk Foundation/BASL/BLT Awards Dr Jay Patel @bedfordhospital Anna Lipinska @NHS_ELFT Dr William Rowley @whistonhospital Dr Tamsin Cargill @Uniofoxford &Dr Ian Rowe @BASLedu Vanessa Hebditch @LiverTrust Maya Vlahovic #FalkUK
1
5
21
@tom_marjot
Tom Marjot
8 days
After 10 happy years of training in Oxford, it's time for something new Delighted to be joining the @Inst_of_Liver at @kingsmedicine Cant wait to join such an amazing team @phil_newsome7 @AHadjihambi @DebbieShawcros1 @DrVishalCPatel @DrAntonioRiva @MichaelHenegha8 @foad_rouhani
@Inst_of_Liver
The Roger Williams Institute of Liver Studies
9 days
Exciting news from @kingsmedicine & @f4liverresearch. Dr @tom_marjot has been appointed to the new King’s College Roger Williams Fellowship in Hepatology at the Roger Williams Institute of Liver Studies. Joining from the University of Oxford in April 2026, Tom’s research will
18
11
82
@tom_marjot
Tom Marjot
10 days
This will be fun! 🔹x2 giants of hepatology 🔹Different journeys & experiences I'll ask the thorny questions so you don't have to 🔸Are you using 'ACLF' on your ward rounds? 🔸Does it aid communication with pts? 🔸How do you use prognostic scores? 🔸Does ACLF allow access to LT?
@EASLedu
EASL Education
10 days
@jackdeliuc @MajaThiele @MzamoMbelle @PoseElisa @rabataller @AleksanderKrag @tom_marjot @ProfPaoloAngeli @BavenoCoop You can watch live tomorrow at 18:00 cet https://t.co/eey2RQMAM3 Or wait for the on demand which will be available y the end of the week on EASL Campus and YouTube
0
3
8
@FrontGastro_BMJ
Frontline Gastro
1 month
🩸 Portal pressure meet your match! 💥 New paper in @FrontGastro_BMJ by @mariej_sinclair👇 📉 Continuous terlipressin infusion (CTI) in decompensated cirrhosis significantly lowers renin & aldosterone ⚖️ Boosts ACE2 activity 🧪 Reduces ACE/ACE2 ratio 🧬 A powerful shift
1
8
24
@UKHaHSoc
UK Hospital at Home Society
13 days
📢 Registered for our Conference? Join #POCUS Training Day 4th March 2026 ➡️ Lung /abdominal/vascular ultrasound ➡️ Hands-on scanning with expert faculty ➡️Designed for all clinicians in #HaH Only 30 places- must be registered for the main conference 🔗 https://t.co/mTykdcAd9T
0
8
9
@RoryStewartUK
Rory Stewart
15 days
What a horrifying terrible attack - all our thoughts and prayers are with the Jewish community who were there and with the Jewish community more widely - and our gratitude to those who responded so bravely.
158
37
693
@docMPK
M PREMKUMAR
17 days
Impact of Cirrhotic cardiomyopathy on outcomes in AKI 🚦Fluid resuscitation and use of vasopressors like terlipressin can be guided by POCUS. 🎯 CCM variables like mitral tissue Doppler offer AKI trajectory prediction Close association of CCM either HRS AKI @HEP_Journal
0
2
10
@docMPK
M PREMKUMAR
17 days
‘Point-of-Care Ultrasound (POCUS) guided volume management... : Hepatology https://t.co/c63bvQA9VZ Now online. #livertwitter @ajay_duseja @drnipunverma @AnandVKulkarni2 @hepocus @Florent_Artru @manhalizzy @ebtapper POCUS to classify volume status in Cirrhosis & AKI Trajectory
5
26
59
@EASLedu
EASL Education
16 days
@MajaThiele @briantleemd @MzamoMbelle @PoseElisa @rabataller @AleksanderKrag Next week: Prognostic scores, multiple definitions, urgent transplants. Does the ACLF concept help or hinder care?🤔 #EASLStudio tackles what truly matters at the bedside. 📅Wednesday, 8 October | 18:00 CEST 🔗 https://t.co/Ewd8THCY80 @tom_marjot @ProfPaoloAngeli @BavenoCoop
1
5
20
@tom_marjot
Tom Marjot
16 days
🏠New concept: Hepatology@Home Delivering expert care to complex patients in the community: Ascitic taps, LVP, antibiotics, diuretics. ✅Feasible ✅Safe ✅Avoids admission It's been v inspiring to watch @TamCarg grow this service from nothing👏 @ebtapper @serperm @NnekaUfereMD
@TamCarg
Tamsin Cargill
17 days
Hep@home: management of patients with liver disease at home @FrontGastro_BMJ⁩ ⁦@UKHaHSoc⁩ ⁦⁦⁩ ⁦⁦@DanLasserson⁩ ⁦⁦⁦⁦⁦@BryonyRChapman⁩ ⁦⁦⁦@Dr_Sam_Mills⁩ ⁦@SophieMcGlen⁩ ⁦⁦@esaunsbury
3
9
25
@esaunsbury
Emma
17 days
Have you heard about Hep@Home? 🏥🏠 40 patients Extra 269 days at home ✅ 156 inpatient bed days saved 💰🛌 ⏳ 113 hospital-based ambulatory reviews avoided A novel and pragmatic approach to improving quality of life for hepatology patients with #frailty. Read more here:
@TamCarg
Tamsin Cargill
17 days
Hep@home: management of patients with liver disease at home @FrontGastro_BMJ⁩ ⁦@UKHaHSoc⁩ ⁦⁦⁩ ⁦⁦@DanLasserson⁩ ⁦⁦⁦⁦⁦@BryonyRChapman⁩ ⁦⁦⁦@Dr_Sam_Mills⁩ ⁦@SophieMcGlen⁩ ⁦⁦@esaunsbury
2
6
9
@UKHaHSoc
UK Hospital at Home Society
17 days
An important step for Hospital at Home development for patients with chronic liver disease
@TamCarg
Tamsin Cargill
17 days
Hep@home: management of patients with liver disease at home @FrontGastro_BMJ⁩ ⁦@UKHaHSoc⁩ ⁦⁦⁩ ⁦⁦@DanLasserson⁩ ⁦⁦⁦⁦⁦@BryonyRChapman⁩ ⁦⁦⁦@Dr_Sam_Mills⁩ ⁦@SophieMcGlen⁩ ⁦⁦@esaunsbury
0
5
6
@TamCarg
Tamsin Cargill
17 days
Increased number of days at home without attending hospital for inpatient admission or hepatology ambulatory review for patients. Especially welcomed by patients with frailty that find repeated hospital attendances difficult and are in their last months of life.
0
0
3
@TamCarg
Tamsin Cargill
17 days
Point of care blood tests and point of care ultrasound #POCUS key. Intravenous medications and procedures including large volume paracentesis performed at home.
1
0
2
@TamCarg
Tamsin Cargill
17 days
Care for patients with complications of liver disease is delivered by acute medical doctors, nurses and AHPs in the home, overseen by hepatology specialists.
1
0
3